IL164163A0 - Process for preparing a finely self-emulsifiable pharmaceutical composition - Google Patents
Process for preparing a finely self-emulsifiable pharmaceutical compositionInfo
- Publication number
- IL164163A0 IL164163A0 IL16416303A IL16416303A IL164163A0 IL 164163 A0 IL164163 A0 IL 164163A0 IL 16416303 A IL16416303 A IL 16416303A IL 16416303 A IL16416303 A IL 16416303A IL 164163 A0 IL164163 A0 IL 164163A0
- Authority
- IL
- Israel
- Prior art keywords
- preparing
- pharmaceutical composition
- pharmaceutically acceptable
- composition
- emulsifiable
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide
- A61K31/635—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide having a heterocyclic ring, e.g. sulfadiazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/02—Halogenated hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37120002P | 2002-04-09 | 2002-04-09 | |
PCT/US2003/010526 WO2003086392A2 (en) | 2002-04-09 | 2003-04-07 | Process for preparing a finely self-emulsifiable pharmaceutical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
IL164163A0 true IL164163A0 (en) | 2005-12-18 |
Family
ID=29250656
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL16416303A IL164163A0 (en) | 2002-04-09 | 2003-03-10 | Process for preparing a finely self-emulsifiable pharmaceutical composition |
Country Status (19)
Country | Link |
---|---|
US (1) | US20030235596A1 (xx) |
EP (1) | EP1492527B1 (xx) |
JP (1) | JP2005529104A (xx) |
KR (1) | KR100779285B1 (xx) |
CN (1) | CN1305470C (xx) |
AT (1) | ATE410162T1 (xx) |
AU (1) | AU2003223485B2 (xx) |
BR (1) | BR0309138A (xx) |
CA (1) | CA2481677A1 (xx) |
DE (1) | DE60323953D1 (xx) |
ES (1) | ES2310653T3 (xx) |
HK (1) | HK1076382A1 (xx) |
IL (1) | IL164163A0 (xx) |
MX (1) | MXPA04009880A (xx) |
PL (1) | PL372807A1 (xx) |
RS (1) | RS87004A (xx) |
RU (1) | RU2299061C2 (xx) |
WO (1) | WO2003086392A2 (xx) |
ZA (1) | ZA200407711B (xx) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10211801B4 (de) | 2002-03-16 | 2004-09-30 | Clariant Gmbh | Kosmetische und pharmazeutische Zubereitungen enthaltend einen oxalkylierten Polyglycerinester |
US9498454B2 (en) | 2003-02-24 | 2016-11-22 | Pharmaceutical Productions Inc. | Transmucosal drug delivery system |
RU2342953C2 (ru) * | 2003-02-24 | 2009-01-10 | Фармасьютикал Продакшенз, Инк. | Трансмукозная система доставки лекарственных средств |
US9358296B2 (en) | 2003-02-24 | 2016-06-07 | Pharmaceutical Productions Inc. | Transmucosal drug delivery system |
US9254294B2 (en) | 2003-02-24 | 2016-02-09 | Pharmaceutical Productions Inc. | Transmucosal hormone delivery system |
JP2006232755A (ja) * | 2005-02-25 | 2006-09-07 | Dai Ichi Kogyo Seiyaku Co Ltd | 油中水型マイクロエマルション |
JP5406529B2 (ja) | 2005-10-26 | 2014-02-05 | バナー ファーマキャプス, インコーポレイテッド | カプセル充墳物としての親油性ベヒクルに基づく二重制御された放出マトリクスシステム |
CN101360485B (zh) * | 2005-10-26 | 2013-04-17 | 班纳制药公司 | 作为胶囊填充物的基于亲水性载体的双重控释基质*** |
US20100119601A1 (en) * | 2007-04-11 | 2010-05-13 | Pharmaceutical Productions Inc. | Melatonin tablet and methods of preparation and use |
EP2488022B1 (en) | 2009-10-16 | 2018-01-10 | Mochida Pharmaceutical Co., Ltd. | Compositions |
AU2010335654B2 (en) * | 2009-12-22 | 2015-04-09 | Leo Pharma A/S | Cutaneous composition comprising vitamin D analogue and a mixture of solvent and surfactants |
AT511045A1 (de) | 2011-01-28 | 2012-08-15 | Blum Gmbh Julius | Möbelteil mit einer drehmomentübertragenden welle |
US8951514B2 (en) | 2011-02-16 | 2015-02-10 | Pivotal Therapeutics Inc. | Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels |
US8952000B2 (en) | 2011-02-16 | 2015-02-10 | Pivotal Therapeutics Inc. | Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events |
US9119826B2 (en) | 2011-02-16 | 2015-09-01 | Pivotal Therapeutics, Inc. | Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels |
EP3936133A1 (en) | 2011-11-23 | 2022-01-12 | TherapeuticsMD, Inc. | Natural combination hormone replacement formulations and therapies |
US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
CN103965113A (zh) * | 2014-05-06 | 2014-08-06 | 四川大学 | 1-羟乙基-2-取代苯氧甲基苯并咪唑类化合物及其制备方法 |
CA2947767A1 (en) | 2014-05-22 | 2015-11-26 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
US11400048B2 (en) | 2014-06-25 | 2022-08-02 | Synergia Bio Sciences Private Limited | Pharmaceutical oil-in-water nano-emulsion |
JP6634034B2 (ja) | 2014-06-25 | 2020-01-22 | シネルジア・バイオ・サイエンシーズ・プライベイト・リミテッドSynergia Bio Sciences Private Limited | 医薬水中油型ナノエマルジョン |
EP3174542A4 (en) | 2014-07-29 | 2018-01-03 | TherapeuticsMD, Inc. | Transdermal cream |
AU2016267685A1 (en) | 2015-05-28 | 2017-12-07 | Dr. Reddy's Laboratories Ltd. | Oral composition of celecoxib for treatment of pain |
US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
CN105343002B (zh) * | 2015-11-27 | 2019-07-26 | 济南康和医药科技有限公司 | 一种依托考昔口服微乳制剂及其制备方法 |
BR112018070199A2 (pt) | 2016-04-01 | 2019-01-29 | Therapeuticsmd Inc | composição farmacêutica de hormônio esteroide |
US10286077B2 (en) | 2016-04-01 | 2019-05-14 | Therapeuticsmd, Inc. | Steroid hormone compositions in medium chain oils |
US11633405B2 (en) | 2020-02-07 | 2023-04-25 | Therapeuticsmd, Inc. | Steroid hormone pharmaceutical formulations |
CN111729125B (zh) * | 2020-07-31 | 2022-10-04 | 陕西佰傲再生医学有限公司 | 骨止血材料 |
CN114681470A (zh) * | 2020-12-28 | 2022-07-01 | 雷迪博士实验室有限公司 | 治疗疼痛的方法 |
CN113750043A (zh) * | 2021-09-18 | 2021-12-07 | 山东省药学科学院 | 一种塞来昔布自乳化口服液及其制备方法 |
KR102635930B1 (ko) | 2021-10-29 | 2024-02-14 | 단국대학교 천안캠퍼스 산학협력단 | 자가나노유화 약물전달시스템을 이용한 셀레콕시브 함유 경구 투여용 제제 및 이의 제조방법 |
GB2616663A (en) * | 2022-03-18 | 2023-09-20 | Alkaloid Ad Skopje | Pharmaceutical formulation |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR7801924A (pt) * | 1977-03-29 | 1978-10-24 | Capsugel Ag | Capsula de seguranca carregada com material viscoso e processo para sua producao |
JP2564889B2 (ja) * | 1988-03-07 | 1996-12-18 | 松下電工株式会社 | 軸流フアン |
US5264223A (en) * | 1990-03-29 | 1993-11-23 | Japan Elanco Company, Ltd. | Hard capsule for pharmaceutical drugs and method for producing the same |
US5474995A (en) * | 1993-06-24 | 1995-12-12 | Merck Frosst Canada, Inc. | Phenyl heterocycles as cox-2 inhibitors |
US5466823A (en) * | 1993-11-30 | 1995-11-14 | G.D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides |
US5756123A (en) * | 1994-12-01 | 1998-05-26 | Japan Elanco Co., Ltd. | Capsule shell |
US5633272A (en) * | 1995-02-13 | 1997-05-27 | Talley; John J. | Substituted isoxazoles for the treatment of inflammation |
US5981576A (en) * | 1995-10-13 | 1999-11-09 | Merck Frosst Canada, Inc. | (Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors |
US5993858A (en) * | 1996-06-14 | 1999-11-30 | Port Systems L.L.C. | Method and formulation for increasing the bioavailability of poorly water-soluble drugs |
US5861419A (en) * | 1996-07-18 | 1999-01-19 | Merck Frosst Canad, Inc. | Substituted pyridines as selective cyclooxygenase-2 inhibitors |
US6034256A (en) * | 1997-04-21 | 2000-03-07 | G.D. Searle & Co. | Substituted benzopyran derivatives for the treatment of inflammation |
EP1112060B1 (en) * | 1998-09-09 | 2005-12-07 | ALZA Corporation | Dosage form comprising liquid formulation |
MY120279A (en) * | 2000-05-26 | 2005-09-30 | Pharmacia Corp | Use of a celecoxib composition for fast pain relief |
TWI232761B (en) * | 2000-07-01 | 2005-05-21 | Pharmaceutical Ind Tech & Dev | Capsule preparation for oral administration and the preparation method thereof |
EP1299122A2 (en) * | 2000-07-13 | 2003-04-09 | Pharmacia Corporation | Combination of a cox-2 inhibitor and a vasomodulator for treating pain and headache pain |
US20030105141A1 (en) * | 2001-04-17 | 2003-06-05 | Ping Gao | Finely self-emulsifiable pharmaceutical composition |
-
2003
- 2003-03-10 IL IL16416303A patent/IL164163A0/xx unknown
- 2003-04-07 US US10/408,934 patent/US20030235596A1/en not_active Abandoned
- 2003-04-07 JP JP2003583411A patent/JP2005529104A/ja active Pending
- 2003-04-07 AT AT03719615T patent/ATE410162T1/de not_active IP Right Cessation
- 2003-04-07 CA CA002481677A patent/CA2481677A1/en not_active Abandoned
- 2003-04-07 AU AU2003223485A patent/AU2003223485B2/en not_active Ceased
- 2003-04-07 KR KR1020047016087A patent/KR100779285B1/ko not_active IP Right Cessation
- 2003-04-07 DE DE60323953T patent/DE60323953D1/de not_active Expired - Fee Related
- 2003-04-07 EP EP03719615A patent/EP1492527B1/en not_active Expired - Lifetime
- 2003-04-07 WO PCT/US2003/010526 patent/WO2003086392A2/en active IP Right Grant
- 2003-04-07 RU RU2004130291/15A patent/RU2299061C2/ru not_active IP Right Cessation
- 2003-04-07 PL PL03372807A patent/PL372807A1/xx not_active Application Discontinuation
- 2003-04-07 RS YU87004A patent/RS87004A/sr unknown
- 2003-04-07 ES ES03719615T patent/ES2310653T3/es not_active Expired - Lifetime
- 2003-04-07 MX MXPA04009880A patent/MXPA04009880A/es not_active Application Discontinuation
- 2003-04-07 BR BR0309138-4A patent/BR0309138A/pt not_active IP Right Cessation
- 2003-04-07 CN CNB038133490A patent/CN1305470C/zh not_active Expired - Fee Related
-
2004
- 2004-09-23 ZA ZA200407711A patent/ZA200407711B/en unknown
-
2005
- 2005-09-23 HK HK05108386A patent/HK1076382A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
MXPA04009880A (es) | 2004-12-07 |
CA2481677A1 (en) | 2003-10-23 |
WO2003086392A3 (en) | 2004-03-25 |
US20030235596A1 (en) | 2003-12-25 |
RU2299061C2 (ru) | 2007-05-20 |
RS87004A (xx) | 2006-12-15 |
CN1658870A (zh) | 2005-08-24 |
CN1305470C (zh) | 2007-03-21 |
AU2003223485B2 (en) | 2007-05-31 |
ZA200407711B (en) | 2006-06-28 |
ATE410162T1 (de) | 2008-10-15 |
HK1076382A1 (en) | 2006-01-20 |
KR100779285B1 (ko) | 2007-11-28 |
KR20070014237A (ko) | 2007-02-01 |
EP1492527B1 (en) | 2008-10-08 |
BR0309138A (pt) | 2005-02-01 |
WO2003086392A2 (en) | 2003-10-23 |
AU2003223485A1 (en) | 2003-10-27 |
DE60323953D1 (de) | 2008-11-20 |
PL372807A1 (en) | 2005-08-08 |
EP1492527A2 (en) | 2005-01-05 |
JP2005529104A (ja) | 2005-09-29 |
RU2004130291A (ru) | 2005-05-27 |
ES2310653T3 (es) | 2009-01-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1076382A1 (en) | Process for preparing a finely self-emulsifiable pharmaceutical composition | |
WO2002056878A3 (en) | Pharmaceutical composition having reduced tendency for drug crystallization | |
CO5580835A2 (es) | Nuevas formulaciones analogas de ciclosporina | |
NO20085078L (no) | Nye forbindelser | |
EA200301019A1 (ru) | Доставляемая перорально фармацевтическая композиция, включающая препарат с низкой растворимостью в воде (ингибитор cox-2), растворитель, жирную кислоту и органический амин | |
BG106439A (en) | Pharmaceutical composition of improved solubility and oral absorptivity, containing benzamide derivative | |
ES2110377T1 (es) | Formulacion galenica de fenofibrato y aplicacion de la misma. | |
DE602004016856D1 (de) | Hfc lösungsformulierungen enthaltend ein anticholinergikum | |
DE602004011966D1 (en) | Heterocyclylverbindungen | |
PL338335A1 (en) | Pharmaceutic composition in the of self-emulsifiable formulation of lipophilic compounds | |
NO20014718L (no) | Formulering inneholdende testosteron-undekanoat og castorolje | |
NO962543L (no) | Cykliske amid-derivater som neurokinin A-antagonister | |
MY129450A (en) | Pharmaceutical composition | |
MA27576A1 (fr) | Nouveaux derives d'azepines tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
NO950134L (no) | Formuleringer for oralt administrerte farmasöytiske midler | |
MX9400165A (es) | Derivados de ter-butilergolina, proceso para su produccion y composiciones farmaceuticas que los contienen. | |
WO2021076847A1 (en) | Compositions comprising quinone and/or quinol and methods of preparations and use thereof | |
ATE293635T1 (de) | Streptograminderivate, ihre herstellung und sie enthaltende zubereitungen | |
IL164763A (en) | Hyperforin derivatives, the use thereof and formulations containing them | |
KR940021524A (ko) | 1,2,5,6-테트라하이드로피리딘 유도체와 이의 제조 방법 및 치료시 이의 이용방법 | |
WO2001097751A3 (en) | New formulation comprising a betablocker and optionally a cholesterol-lowering agent | |
WO2001053322A3 (en) | Aerothricin analogs, their preparation and use | |
ATE252598T1 (de) | Streptograminderivate, ihre herstellung und sie enthaltende zubereitungen | |
TH40972B (th) | สารประกอบอินทรีย์ | |
TH40972A3 (th) | สารประกอบอินทรีย์ |